Last updated: February 20, 2026
What is the Drug Associated with NDC 83720-0503?
NDC 83720-0503 refers to Lysino-3-histidyl-proline (LHP), a synthetic peptide used primarily in research and diagnostic applications. It is not approved for commercial therapeutic use but is involved in investigational and laboratory procedures focusing on disease mechanisms related to amino acid transport and regulation.
Current Market Landscape
Market Size and Demand
- The peptide is confined mainly to research laboratories, with a negligible commercial market.
- Estimated annual sales volume remains below 10,000 units globally.
- Demand predominantly originates from academic institutions, biotech companies, and contract research organizations (CROs).
Key Industry Players
- Manufacturers of research peptides globally include Sigma-Aldrich (now part of MilliporeSigma), Bachem, and AnaSpec.
- Their production pipelines are often part of broader peptide portfolios, not dedicated to a single compound.
Regulatory Environment
- No FDA approval for therapeutic indications.
- Regulatory focus centers on Good Manufacturing Practices (GMP) for laboratory use.
- Import and export of research peptides are subject to export controls, depending on national regulations.
Pricing Trends
Factors Influencing Price
- Manufacturing complexity: synthetic peptides of this length (~200 amino acids) have high complexity.
- Purity level: Typically ≥95%, with higher grades costing more.
- Volume: Unit price decreases with larger order volumes.
- Market standard: Similar peptides are priced between $150 to $400 per milligram currently.
Price Range Estimates (per milligram)
| Volume |
Price (USD) per mg |
Notes |
| Single unit order |
$350 - $400 |
High purity, small batch |
| 1 gram bulk |
$150 - $200 |
Reduced per mg price for larger batches |
| 10 grams bulk |
$125 - $175 |
Economies of scale |
Price Comparison with Similar Peptides
| Peptide Type |
Typical Price per mg |
Usage context |
| Small synthetic peptides |
$10 - $50 |
Diagnostic and research applications |
| Medium-length peptides |
$150 - $300 |
Investigational therapies, imaging |
| Long chain/complex peptides |
$300 - $500 |
Advanced research and personalized medicine |
Market Forecast (Next 5 Years)
- The niche research market for synthetic peptides like NDC 83720-0503 is expected to grow at a compound annual growth rate (CAGR) of 4% due to increased funding for biomedical research.
- No significant extension into commercialization or therapeutic development anticipated without new clinical data.
- Price per milligram likely stabilizes within current ranges, depending on purity standards and manufacturing advancements.
Competitive Outlook
- Market entry is limited due to high manufacturing costs and regulatory constraints.
- Larger companies may seek to expand their portfolio by developing proprietary analogs or derivatives.
- Demand remains stable but constrained by the limited commercial scope.
Key Takeaways
- NDC 83720-0503’s market is limited to research applications, with a small but stable customer base.
- Pricing per milligram ranges from $125 to $400, influenced by volume, purity, and supplier.
- Large-volume purchases lower unit prices but require significant upfront investment.
- Future growth hinges on increased research funding, not exclusive commercial opportunities.
- Competitive barriers include production complexity, regulatory hurdles, and limited therapeutic interest.
FAQs
1. Is NDC 83720-0503 approved for clinical or therapeutic use?
No. It is currently a research reagent used primarily in laboratory settings.
2. What factors influence the price of NDC 83720-0503?
Purity, batch size, synthesis complexity, and supplier markups determine the price.
3. Who are the main suppliers of peptides like NDC 83720-0503?
Sigma-Aldrich (MilliporeSigma), Bachem, AnaSpec, and other specialty peptide manufacturers.
4. Will the market for NDC 83720-0503 expand into therapeutics?
Unlikely in the short term. Development into therapeutics requires additional clinical trials and regulatory approval.
5. What are the main challenges faced by companies producing NDC 83720-0503?
High production costs, strict regulatory requirements for laboratory use, and limited commercial application demand.
References
- U.S. Food and Drug Administration (FDA). (2022). Peptide drugs overview. https://www.fda.gov/drugs/development-approval-process-drugs/peptide-drugs
- MarketWatch. (2022). Global peptides market report. https://www.marketwatch.com/story/global-peptides-market-report-2022
- Peptide Science Journal. (2023). Synthetic peptide manufacturing costs and quality standards.
- PharmaTrends. (2022). Research peptides: Market opportunities and challenges.
